The researchers found that FeNO showed different associations with exacerbations across asthma, COPD, and asthma-COPD overlap ...
Please provide your email address to receive an email when new articles are posted on . “We found a stepwise greater loss of lung density with increasing exacerbation frequency, predominantly in ...
Patient-reported symptoms in chronic obstructive pulmonary disease may contribute information that can be used to infer future exacerbations and related costs. Patient-reported symptoms in chronic ...
Please provide your email address to receive an email when new articles are posted on . Risk estimation was based on area under the receiver operating characteristic curve, sensitivity and specificity ...
—A new study finds that some patients are proactive (they seek immediate treatment), while others tough it out (wishing to avoid the ‘hassle’ or ‘inconvenience’). What can clinicians do to better ...
According to a recent study, patients with an exacerbation of chronic obstructive pulmonary disease (COPD) have greater risks of both subsequent exacerbations and mortality. The odds of subsequent ...
Credit: Scott Bodell/MedicalImages.com The authors outline preventative pharmacologic therapies for COPD exacerbations and a patient-tailored approach to management. Chronic obstructive pulmonary ...
A recent study explored exacerbation history to determine what it revealed about prognosis. The findings suggested that exacerbation severity history was predictive of future exacerbation status.
ATS 2016, SAN FRANCISCO -- In patients with chronic obstructive pulmonary disease (COPD), exacerbations accelerated lung function loss, according to a new study presented at the ATS 2016 International ...
Acute exacerbations of chronic obstructive pulmonary disease, or COPD, are associated with significant long-term lung function loss, according to research published online, ahead of print in the ...
Patients with acute COPD exacerbations are seen frequently in the emergency department (ED). Acute exacerbations are associated with significant morbidity, mortality and health care expenditures.
Pharmaceutical Technology on MSN
GSK’s Nucala secures NICE COPD endorsement
NICE now recommends Nucala for both severe asthma and COPD, expanding the drug’s clinical uptake across the UK’s public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results